Skip to main content
. 2019 Apr 17;17(6):4344–4356. doi: 10.3892/etm.2019.7499

Table VI.

Histological evaluation at 6 weeks.

Mean ± standard deviation

Variable CTL group PRP group PRP + SC group Kruskal-Wallis P-value Kruskall Wallis post-hoc multiple comparison with Bonferroni's correction P-value
Tissue morphology 3.83±0.41 3.50±0.53 3.86±0.38 0.216
Matrix staining 3.83±0.41 3.40±0.70 3.86±0.38 0.193
Structural integrity 4.0±0.00 3.60±0.52 4.00±0.00 0.050
Chondrocyte clustering in implant 2.00±0.00 1.80±0.42 2.43±0.53 0.025a CTL × PRP, P=1,000
CTL × PRP+SC, P=0.699
PRP × PRP+SC, P=0.155
Intactness of calcified layer, formation of tidemark 1.17±0.41 1.90±1.10 1.57±0.53 0.280
Subchondral bone formation 2.00±0.00 2.40±0.52 2.29±0.49 0.222
Histological assessment of surface architecture 2.00±0.00 2.50±0.53 3.86±0.38 <0.001a CTL × PRP, P=0.675
aCTL × PRP+SC, P=0.001
aPRP × PRP+SC, P=0.015
Histological assessment of defect filling 4.83±0.41 4.50±0.53 5.00±0.00 0.065
Lateral integration of implanted material 2.00±0 2.10±0.32 3.00±0 <0.001a CTL × PRP, P=1.000
aCTL × PRP+SC, P=0.007
aPRP × PRP+SC, P=0.006
Basal integration of implanted material 3.00±0 3.50±0.53 3.43±0.79 0.156
Inflammation: Maximum total score 1.00±0 1.40±0.84 1.00±0 0.256
Total score 29.67±1.03 30.60±4.30 34.29±1.60 0.047a CTL × PRP, P=1,000
CTL × PRP+SC, P=0.062
PRP × PRP+SC, P=0.164
a

P<0.05. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP + SC, group treated with platelet-rich plasma plus human dental pulp stem cells.